Vitamin D, nervous system and aging
- PMID: 19660871
- DOI: 10.1016/j.psyneuen.2009.07.003
Vitamin D, nervous system and aging
Abstract
This is a mini-review of vitamin D(3), its active metabolites and their functioning in the central nervous system (CNS), especially in relation to nervous system pathologies and aging. The vitamin D(3) endocrine system consists of 3 active calcipherol hormones: calcidiol (25OHD(3)), 1alpha-calcitriol (1alpha,25(OH)2D(3)) and 24-calcitriol (24,25(OH)2D(3)). The impact of the calcipherol hormone system on aging, health and disease is discussed. Low serum calcidiol concentrations are associated with an increased risk of several chronic diseases including osteoporosis, cancer, diabetes, autoimmune disorders, hypertension, atherosclerosis and muscle weakness all of which can be considered aging-related diseases. The relationship of many of these diseases and aging-related changes in physiology show a U-shaped response curve to serum calcidiol concentrations. Clinical data suggest that vitamin D(3) insufficiency is associated with an increased risk of several CNS diseases, including multiple sclerosis, Alzheimer's and Parkinson's disease, seasonal affective disorder and schizophrenia. In line with this, recent animal and human studies suggest that vitamin D insufficiency is associated with abnormal development and functioning of the CNS. Overall, imbalances in the calcipherol system appear to cause abnormal function, including premature aging, of the CNS.
Similar articles
-
Vitamin D and aging.J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):78-84. doi: 10.1016/j.jsbmb.2008.12.020. J Steroid Biochem Mol Biol. 2009. PMID: 19444937 Review.
-
Vitamin D, aging, and cancer.Nutr Rev. 2008 Oct;66(10 Suppl 2):S147-52. doi: 10.1111/j.1753-4887.2008.00095.x. Nutr Rev. 2008. PMID: 18844842 Review.
-
Assessing vitamin D in the central nervous system.Acta Neurol Scand Suppl. 2010;(190):88-92. doi: 10.1111/j.1600-0404.2010.01383.x. Acta Neurol Scand Suppl. 2010. PMID: 20586743 Review.
-
Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.Bone. 2013 Oct;56(2):271-5. doi: 10.1016/j.bone.2013.06.012. Epub 2013 Jun 20. Bone. 2013. PMID: 23792937 Clinical Trial.
-
Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent.Curr Med Res Opin. 2013 Nov;29(11):1565-72. doi: 10.1185/03007995.2013.838549. Epub 2013 Sep 13. Curr Med Res Opin. 2013. PMID: 24020910 Review.
Cited by
-
The Interrelated Multifactorial Actions of Cortisol and Klotho: Potential Implications in the Pathogenesis of Parkinson's Disease.Brain Sci. 2022 Dec 10;12(12):1695. doi: 10.3390/brainsci12121695. Brain Sci. 2022. PMID: 36552155 Free PMC article. Review.
-
Low serum 25-hydroxyvitamin d concentrations are associated with increased risk for melanoma and unfavourable prognosis.PLoS One. 2014 Dec 1;9(12):e112863. doi: 10.1371/journal.pone.0112863. eCollection 2014. PLoS One. 2014. PMID: 25437008 Free PMC article.
-
ROS and brain diseases: the good, the bad, and the ugly.Oxid Med Cell Longev. 2013;2013:963520. doi: 10.1155/2013/963520. Epub 2013 Dec 5. Oxid Med Cell Longev. 2013. PMID: 24381719 Free PMC article. Review.
-
Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation.Dermatoendocrinol. 2009 Nov;1(6):289-93. doi: 10.4161/derm.1.6.11359. Dermatoendocrinol. 2009. PMID: 21572873 Free PMC article.
-
1,25 Dihydroxyvitamin D3 uptake is localized at caveolae and requires caveolar function.J Biomed Nanotechnol. 2013 Oct;9(10):1707-15. doi: 10.1166/jbn.2013.1662. J Biomed Nanotechnol. 2013. PMID: 24015500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical